EraCal Therapeutics is focused on developing solutions for fighting obesity.

EraCal Therapeutics

EraCal Therapeutics  | 1,964 followers on LinkedIn. Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-vivo screening platform | The biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.

Attorney at Law, LL.M., Senior Associate at VISCHER AG

Pauline Pfirter

COO and Co-founder of Eracal Therapeutics

Simon Breitler

Senior Scientist bei EraCal Therapeutics

Stephanie Niklaus

We are thrilled to see our deal with Novo Nordisk has made the finals of the European Lifestars Awards - Celebrating Life Science Leaders . Looking forward to the ceremony in London next week. https://lnkd.in/dNeDbkCx

Proud to be selected in the Top 5 of Swiss biotech scale-ups 2024. https://lnkd.in/dV2-eDzE

Congratulations to Pauline Pfirter MLaw, LL.M. who was unanimously elected to the board of directors of EraCal Therapeutics. Welcome to the team Pauline, we are looking forward to shaping the future of EraCal Therapeutics together. https://www.eracal.ch/news

EraCal Therapeutics enters into a Collaboration and License Agreement with Novo Nordisk

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 7:37 PM	368a57a9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 7:37 PM	800f83ef
crunchbase trigger	general	Nov 12, 2024 7:37 PM	e6d65d1d
crunchbase profile	general
li profile	general	Nov 12, 2024 7:37 PM	888c016b
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 7:37 PM	e7d91041
news basic	general	Nov 12, 2024 7:37 PM	7cc236be
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ERAC

CH:ERACAL

EraCal Therapeutics